Intuitive Surgical, Inc.
NASDAQ:ISRGMedical - Devices
+$3.65 today
- Market cap
- $145.92B
- Beta
- 1.45
- P/E (TTM)
- 48.3
- EPS (TTM)
- $8.39
Volume 2.20M
Average 2.21M
ISRG EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Intuitive Surgical, Inc.NASDAQ: ISRG
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA dips below year-ago levels
Q3 FY2026 EBITDA of $668.4M fell 34.2% year over year, behind the +11.9% change in trailing-twelve-month EBITDA. Sequentially, it fell 44.5% from the prior quarter. Over 3 fiscal years it compounded at +26.5% a year.
Context
- EBITDA amounted to 39.6% of revenue in FY2025, up 2.1 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 24 analysts of $5.44B (+36.5%) for the fiscal year ending Dec 2026, a step up from the +27.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $668.4M-44.5% QoQ
- Last fiscal yearDec 2025
- $3.99B+27.2% YoY
- LTMSep 2026
- $4.19B+11.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -34.2% | +21.2% | +55.4 pp |
| 1 year | +27.2% | +36.5% | +9.3 pp |
| 3-year CAGR | +26.5% | +18.4% | -8.1 pp |
| 5-year CAGR | +16.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 3.99B USD
- Year-over-year change
- +27.2%
- 4-year CAGR
- +16.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.99B | +27.2% |
| FY2024 | 2024-12-31 | 3.14B | +29.9% |
| FY2023 | 2023-12-31 | 2.41B | +22.4% |
| FY2022 | 2022-12-31 | 1.97B | -10.4% |
| FY2021 | 2021-12-31 | 2.2B | — |
EBITDA vs competitors
How ISRG compares with its peers on the latest reported figures
- ISRG's LTM Sep 2026 EBITDA of $4.19B is the 2nd highest of the 5 companies compared; the peer median is $752.81M.
- Its year-over-year change of +11.9% is the 2nd highest of 5, against a peer median of -11.1%.
- EBITDA amounts to 36.2% of revenue for ISRG, versus a peer median of 23.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.69B | +40.7% | +16.3% | 25.9% | |
| LTM Sep 2026 | $4.19B | +11.9% | +26.5% | 36.2% | |
| FY2025 | $1.34B | +0.1% | +5.1% | 21.7% | |
| LTM Mar 2026 | $169.63M | -31.6% | +170.6% | 12.4% | |
| LTM Mar 2026 | -$14.17M | -22.2% | — | 13493.3% | |
| Peer median (excluding ISRG) | $752.81M | -11.1% | +16.3% | 23.8% | |
Competitors are the stored peer set for ISRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.71B | 6.22B | 7.12B | 8.35B | 10.06B |
| Cost of Revenue | 1.75B | 2.03B | 2.39B | 2.72B | 3.42B |
| Gross Profit | 3.96B | 4.2B | 4.73B | 5.63B | 6.64B |
| Gross Margin | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| Research & Development | 671M | 879M | 998.8M | 1.15B | 1.31B |
| Selling, General & Admin | 1.47B | 1.74B | 1.96B | 2.14B | 2.39B |
| Operating Expenses | 2.14B | 2.62B | 2.96B | 3.29B | 3.7B |
| Depreciation & Amortization | 310.2M | 365.8M | 454.8M | 462M | 677.1M |
| EBITDA | 2.2B | 1.97B | 2.41B | 3.14B | 3.99B |
| EBITDA Margin | 38.5% | 31.7% | 33.9% | 37.5% | 39.6% |
| Operating Income | 1.82B | 1.58B | 1.77B | 2.35B | 2.95B |
| Operating Margin | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% |
| Interest Income | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M |
| Income Before Tax | 1.89B | 1.61B | 1.96B | 2.67B | 3.31B |
| Pre-Tax Margin | 33.1% | 25.8% | 27.5% | 32.0% | 32.9% |
| Income Tax Expense | 162.2M | 262.4M | 141.6M | 336.3M | 434.8M |
| Net Income | 1.7B | 1.32B | 1.8B | 2.32B | 2.86B |
| Net Margin | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| EPS (Basic) | 4.79 | 3.72 | 5.12 | 6.54 | 8.00 |
| EPS (Diluted) | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 |
| Weighted Avg Shares | 356.1M | 355.7M | 351.2M | 355.2M | 356.9M |
| Weighted Avg Shares (Diluted) | 365.8M | 362M | 357.4M | 362M | 362.7M |
Intuitive Surgical, Inc.
NASDAQ:ISRG
Intrinsic Alpha fair value
Locked
Current Price
$420.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.